CN Stock MarketDetailed Quotes

300347 Hangzhou Tigermed Consulting

Watchlist
  • 48.99
  • +0.15+0.31%
Market Closed Sep 13 15:00 CST
42.37BMarket Cap37.51P/E (TTM)

Hangzhou Tigermed Consulting Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tigermed Consulting H1 FY2024 Earnings Date

Currency：CNYAug 28, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.76B
3.36B
-401.76M
Miss Est.
+1.32%
-9.50%
-19.21%
EPS
--
0.58
--
-63.82%
Analyst Rating
Strong Buy

Sep 15, 2024

Hangzhou Tigermed Consulting Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.483B--
--2024/Q3-- / 2.148B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.483B--
--2024/Q3-- / 2.148B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--

Unlock Free Earnings Estimates

Hangzhou Tigermed Consulting Earnings Reports

  • Tiger Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Tiger Pharmaceuticals: Semi-Annual Report 2024

    Aug 28 12:00 ET

  • Hangzhou Tigermed Consulting: 2024 First Quarter Report

    Apr 25 12:00 ET

  • Tiger Pharmaceuticals: 2023 Annual Report

    Mar 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 15, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data